Lower levels of iron and % transferrin saturation with increased levels of LH in non-anemic patients suggest systemic changes that influence iron handling; specifically, sex hormones may modulate extracellular iron availability in the tumor microenvironment, possibly by affecting hepatic transferrin expression or iron sequestration by tumor cells [25,26]. This evidence concerns the gene PLOD1 and neoplasm.